Approval Event definition

Approval Event means the earliest date on which all of the following conditions are met: 1.3.1 Settlement Class Notice has been provided to Settlement Class Members by mail or as the Court may otherwise determine is appropriate; 1.3.2 The Settlement Order and Judgment approving the terms of this Agreement, in substantially the form provided herein, has been entered; and 1.3.2.1 No objection was heard at the time of entry of the Settlement Order and Judgment because no objection was filed or any objection filed was withdrawn; 1.3.2.2 If any objection was filed and not withdrawn, the time for appeal from the entry of the Settlement Order and Judgment has expired without appeal; or 1.3.2.3 The Settlement Order and Judgment has been affirmed following any appeal. In the event such an appeal is filed but on grounds that Class Representative and Burlington agree should not preclude completion of the settlement, Class Representative and Burlington may agree in writing to waive this Paragraph 1.3.2.3 and consider the Approval Event to have occurred.

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Approval Event is the receipt of the final NDA approval by Borrower from the U.S. Food and Drug Administration for Borrower’s drug candidate currently named PEDMARK on or before December 31, 2020.

Approval Event means (i) any governmental approval not being granted or being materially delayed upon application having been duly made that complies with the requirements for such approval to be granted, or (ii) any governmental approval ceasing to remain in full force and effect, or not being renewed upon application having been duly made that complies with the requirements for such renewal to be granted.

Examples of Approval Event in a sentence

Upon the occurrence of a Nasdaq Stockholder Required Approval Event, the Company shall immediately use its best efforts to allow it to make any adjustment required under this Section 2.
Without limiting the generality of the foregoing, upon the occurrence of a Nasdaq Stockholder Required Approval Event, the Company shall, as soon as practicable after the date of the occurrence thereof, but in no event later than seventy-five (75) days after the occurrence thereof, hold a meeting of its shareholders for the approval of the issuance of Warrant Shares in excess of any then current Nasdaq restrictions on any such issuance (“Excess Warrant Shares”).
Notwithstanding the foregoing, if at any such time of a Nasdaq Stockholder Required Approval Event, the Company is able to obtain the written consent of a majority of its issued and outstanding shares of Common Stock to approve the issuance of Excess Warrant Shares, the Company may satisfy its obligations pursuant to the immediately preceding sentence by obtaining such written consent and submitting for filing with the SEC an Information Statement on Schedule 14C.
Upon the occurrence of a NYSE Stockholder Required Approval Event, the Company shall as soon as reasonably practicable use reasonable efforts to allow it to make any adjustment required under this Section 3(b).
Without limiting the generality of the foregoing, upon the occurrence of a NYSE Stockholder Required Approval Event, the Company shall, as soon as reasonably practicable after the date of the occurrence thereof, hold a meeting of its stockholders for the approval of the issuance of additional Warrant Shares in excess of any then current NYSE restrictions on any such issuance (“Excess Warrant Shares”).
Section 3.02 The Trustees have no duty to determine or otherwise monitor whether a Common Stock Approval Event, a Preferred Stock Approval Event, a Supervisory Event or Market Disruption Event has occurred or whether any adjustments or actions set forth herein should be made, how they should be made or what they should be.
Notwithstanding the foregoing, if any such time of a Nasdaq Stockholder Required Approval Event, the Company is able to obtain the written consent of a majority of the shares of its issued and outstanding shares of Common Stock to approve the issuance of Excess Warrant Shares, the Company may satisfy this obligation by obtaining such consent and submitting for filing with the SEC an Information Statement on Schedule 14C.
The Company shall not be obligated to sell common stock or to apply such net proceeds or any portion thereof to the payment of Deferred Interest during the occurrence and continuation of a Common Stock Approval Event.
Notwithstanding the foregoing, if any such time of a NYSE Stockholder Required Approval Event, the Company is able to obtain the written consent of a majority of the shares of its issued and outstanding shares of Common Stock to approve the issuance of Excess Warrant Shares, the Company may satisfy this obligation by obtaining such consent and submitting for filing with the SEC an Information Statement on Schedule 14C.
The Company shall not be obligated to sell Preferred Stock or to apply such net proceeds or any portion thereof to the payment of Deferred Interest during the occurrence and continuation of a Preferred Stock Approval Event.

More Definitions of Approval Event

Approval Event means Borrower has delivered evidence reasonably acceptable to Agent and each Lender, after the Closing Date, but on or before October 31, 2014, that ILUVIEN has been approved by the United States Food and Drug Administration with a label generally consistent with what was presented to Lender prior to the Closing Date.

Approval Event means Borrower provides Lenders with evidence, satisfactory to the Lenders in their sole and absolute discretion that Borrower has filed for 510(k) approval for either the Endolinear Stapling or Vessel Sealing indications before December 31, 2012.

Approval Event means the quality assurance process undertaken by NTU to ensure that students on the [UIBS] Courses undergo a comparable learning experience, underpinned by adequate systems and resources and sound and effective quality assurance (QA) processes;

Approval Event is the receipt of the final NDA approval by Borrower from the U.S. Food and Drug Administration for Borrower’s drug candidate currently named PEDMARK on or before September 30, 2022. “Second Draw Period” is the period commencing of the date of the occurrence of the Approval Event and ending on the earlier of (i) September 30, 2022 and (ii) the occurrence of an Event of Default; provided, however, that the Second Draw Period shall not commence if on the date of the occurrence of the Approval Event an Event of Default has occurred and is continuing.

Approval Event is the receipt of the final NDA approval by Borrower from the U.S. Food and Drug Administration for Borrower’s drug candidate currently named PEDMARK on or before January 31, 2022. “First Draw Period” is the period commencing of the date of the occurrence of the Submission Event and ending on the earlier of (i) June 30, 2021 and (ii) the occurrence of an Event of Default; provided, however, that the First Draw Period shall not commence if on the date of the occurrence of the Submission Event an Event of Default has occurred and is continuing.